Applicant, as named in the Orange Book

Crescita Therap

Next listed expiry: Pliaglis on 14 Jan 2031. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Pliaglis NDA 021717 lidocaine; tetracaine	lidocaine; tetracaine	14 Jan 2031 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.